Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alisa Hoffman

Pediatrics Narberth, PA Medical Doctor

NPI 1760563043 CMS profile 307334

617 Braeburn Ln, Suite 300, Narberth, PA 19072

Open in the dashboard

General payments

$1,566

90 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alisa Hoffman of Narberth, PA is reported in the CMS Open Payments database as having received $1,566 across 90 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $39 2
2024 General $66 6
2023 General $22 1
2022 General $597 32
2021 General $212 12
2020 General $289 17
2019 General $341 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alisa Hoffman
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Alisa Hoffman were reported at $39. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Alisa Hoffman Pediatrics median Middle half National median
2019 $341 $86 $31–$183 $163
2020 $289 $49 $22–$110 $114
2021 $212 $68 $27–$158 $132
2022 $597 $77 $30–$173 $149
2023 $22 $88 $33–$190 $160
2024 $66 $94 $34–$206 $164
2025 $39 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ironshore Pharmaceuticals Inc. $230 12 payments
  2. kaleo, Inc. $229 12 payments
  3. Corium, Inc. $210 15 payments
  4. Neos Therapeutics, LP $201 12 payments
  5. Tris Pharma Inc $144 9 payments
  6. Supernus Pharmaceuticals, Inc. $117 5 payments
  7. Adlon Therapeutics L.P. $97 5 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $48 3 payments
  9. Pfizer Inc. $48 3 payments
  10. Collegium Pharmaceutical, Inc. $39 2 payments
  11. Other $204 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,566 90 payments
Products named General payments · program years 2019–2025
  1. AUVI-Q $229 12 payments
  2. Azstarys $210 15 payments
  3. JORNAY PM $176 9 payments
  4. Quillivant XR $125 8 payments
  5. QELBREE $117 5 payments
  6. Adzenys XR-ODT Adhd $111 7 payments
  7. ADHANSIA XR $97 5 payments
  8. COTEMPLA XR-ODT $90 5 payments
  9. Adzenys XR-ODT Adhd $55 3 payments
  10. Jornay PM 20mg capsules (Bottle of 100) $54 3 payments
  11. Other $419 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

90 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record